Spots Global Cancer Trial Database for stage iv pancreatic cancer
Every month we try and update this database with for stage iv pancreatic cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors | NCT00667641 | Breast Cancer Colorectal Canc... Head and Neck C... Lung Cancer Melanoma (Skin) Ovarian Cancer Pancreatic Canc... Prostate Cancer Unspecified Adu... | bortezomib paclitaxel | 18 Years - | Rutgers, The State University of New Jersey | |
| Interleukin-12 in Treating Patients With Cancer in the Abdomen | NCT00003046 | Anal Cancer Colorectal Canc... Gallbladder Can... Gastric Cancer Pancreatic Canc... | Recombinant Int... | 18 Years - | M.D. Anderson Cancer Center | |
| Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer | NCT00274885 | Cancer | oxaliplatin management of t... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Patients With Stage III or Stage IV Pancreatic Cancer That Cannot Be Removed by Surgery | NCT00004003 | Pancreatic Canc... | cisplatin fluorouracil gemcitabine hyd... | 18 Years - | Barbara Ann Karmanos Cancer Institute | |
| Fluorouracil, Gemcitabine, and Radiation Therapy in Treating Patients With Cancer of the Pancreas | NCT00003216 | Pancreatic Canc... | fluorouracil gemcitabine hyd... radiation thera... | 18 Years - | Radiation Therapy Oncology Group | |
| Positron Emission Tomography Using [18F]-Labeled Substance P Antagonist Receptor Quantifier in Finding Disease in Patients With Pancreatic Cancer | NCT00547612 | Pancreatic Canc... | high performanc... pharmacological... [18F]-labeled s... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Ipilimumab and Gemcitabine Hydrochloride in Treating Patients With Stage III-IV or Recurrent Pancreatic Cancer That Cannot Be Removed by Surgery | NCT01473940 | Duct Cell Adeno... Recurrent Pancr... Stage III Pancr... Stage IV Pancre... | ipilimumab gemcitabine hyd... laboratory biom... | 18 Years - | Northwestern University | |
| Sirolimus and Vismodegib in Treating Patients With Solid Tumors or Pancreatic Cancer That is Metastatic or Cannot Be Removed By Surgery | NCT01537107 | Acinar Cell Ade... Duct Cell Adeno... Recurrent Pancr... Stage IV Pancre... Unspecified Adu... | vismodegib sirolimus positron emissi... computed tomogr... pharmacological... laboratory biom... fludeoxyglucose... | 18 Years - | Mayo Clinic | |
| BMS-247550 in Treating Patients With Advanced Pancreatic Cancer | NCT00016965 | Pancreatic Canc... | ixabepilone | 18 Years - | National Cancer Institute (NCI) | |
| Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer | NCT00005842 | Cancer | trastuzumab tipifarnib | 18 Years - | National Cancer Institute (NCI) | |
| Gemcitabine, Nab-paclitaxel and KPT-330 in Advanced Pancreatic Cancer | NCT02178436 | Acinar Cell Ade... Duct Cell Adeno... Stage IV Pancre... | gemcitabine hyd... Selinexor Pharmacological... Laboratory Biom... Nab paclitaxel | 19 Years - | Barbara Ann Karmanos Cancer Institute | |
| Arsenic Trioxide in Treating Patients With Pancreatic Cancer That Has Not Responded to Gemcitabine | NCT00053222 | Pancreatic Canc... | arsenic trioxid... | 18 Years - | University of Chicago | |
| Assessing the Efficacy and Safety of IV Vitamin C in Combination With Standard Chemotherapy for Pancreatic Ca | NCT01555489 | Stage IV Pancre... | Ascorbic Acid | 18 Years - | Thomas Jefferson University | |
| Gemcitabine and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer | NCT00268411 | Pancreatic Canc... | gemcitabine hyd... oxaliplatin | 18 Years - | National Cancer Institute (NCI) | |
| Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers | NCT01846520 | Healthy Subject Localized Trans... Metastatic Tran... Psychosocial Ef... Recurrent Bladd... Recurrent Cervi... Recurrent Colon... Recurrent Gastr... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Recta... Recurrent Renal... Recurrent Trans... Recurrent Ureth... Recurrent Uteri... Regional Transi... Stage II Bladde... Stage II Renal ... Stage II Urethr... Stage IIA Cervi... Stage IIA Colon... Stage IIA Gastr... Stage IIA Ovari... Stage IIA Ovari... Stage IIA Pancr... Stage IIA Recta... Stage IIA Uteri... Stage IIB Cervi... Stage IIB Colon... Stage IIB Gastr... Stage IIB Ovari... Stage IIB Ovari... Stage IIB Pancr... Stage IIB Recta... Stage IIB Uteri... Stage IIC Colon... Stage IIC Ovari... Stage IIC Ovari... Stage IIC Recta... Stage III Bladd... Stage III Pancr... Stage III Renal... Stage III Ureth... Stage IIIA Cerv... Stage IIIA Colo... Stage IIIA Gast... Stage IIIA Ovar... Stage IIIA Ovar... Stage IIIA Rect... Stage IIIA Uter... Stage IIIB Cerv... Stage IIIB Colo... Stage IIIB Gast... Stage IIIB Ovar... Stage IIIB Ovar... Stage IIIB Rect... Stage IIIB Uter... Stage IIIC Colo... Stage IIIC Gast... Stage IIIC Ovar... Stage IIIC Ovar... Stage IIIC Rect... Stage IIIC Uter... Stage IV Bladde... Stage IV Gastri... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Renal ... Stage IV Urethr... Stage IVA Cervi... Stage IVA Colon... Stage IVA Recta... Stage IVA Uteri... Stage IVB Cervi... Stage IVB Colon... Stage IVB Recta... Stage IVB Uteri... Ureter Cancer Stage IIA Lung ... Stage IIB Lung ... Stage IIIA Lung... Stage IIIB Lung... | educational int... telephone-based... quality-of-life... questionnaire a... | 18 Years - | City of Hope Medical Center | |
| Dovitinib Lactate, Gemcitabine Hydrochloride, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Solid Tumors or Pancreatic Cancer | NCT02048943 | Duct Cell Adeno... Recurrent Pancr... Stage III Pancr... Stage IV Pancre... Unspecified Adu... | dovitinib lacta... gemcitabine hyd... paclitaxel albu... pharmacological... laboratory biom... | 18 Years - | Roswell Park Cancer Institute | |
| MK0752 and Gemcitabine Hydrochloride in Treating Patients With Stage III and IV Pancreatic Cancer That Cannot Be Removed by Surgery | NCT01098344 | Pancreatic Canc... | Notch signaling... gemcitabine hyd... imaging biomark... laboratory biom... pharmacological... | 18 Years - | Cancer Research UK | |
| Phase I Trial of LCL161 and Gemcitabine Plus Nab-Paclitaxel in Metastatic Pancreatic Cancer | NCT01934634 | Metastatic Panc... | LCL161 Gemcitabine nab-Paclitaxel | 18 Years - | US Oncology Research | |
| Eribulin Mesylate as Second-Line Therapy for Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer Patients | NCT00383760 | Adenocarcinoma ... Pancreatic Canc... Recurrent Pancr... Stage II Pancre... Stage III Pancr... Stage IV Pancre... | eribulin mesyla... | 18 Years - | National Cancer Institute (NCI) | |
| Ceritinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Locally Advanced or Metastatic Pancreatic Cancer | NCT02227940 | Advanced Malign... ALK Positive Metastatic Panc... Stage III Pancr... Stage IV Pancre... | Ceritinib Cisplatin Gemcitabine Hyd... Laboratory Biom... Paclitaxel Albu... Pharmacological... | 18 Years - | Roswell Park Cancer Institute | |
| Sunitinib in Treating Patients With Metastatic Pancreatic Cancer That Progressed After First-Line Therapy With Gemcitabine | NCT00397787 | Acinar Cell Ade... Duct Cell Adeno... Recurrent Pancr... Stage IV Pancre... | sunitinib malat... | 18 Years - | National Cancer Institute (NCI) | |
| Maytansinoid DM4-Conjugated Humanized Monoclonal Antibody huC242 in Treating Patients With Solid Tumors | NCT00352131 | Non-colorectal ... Pancreatic Canc... | HuC242-DM4 | 18 Years - | ImmunoGen, Inc. | |
| Interleukin-12 in Treating Patients With Cancer in the Abdomen | NCT00003046 | Anal Cancer Colorectal Canc... Gallbladder Can... Gastric Cancer Pancreatic Canc... | Recombinant Int... | 18 Years - | M.D. Anderson Cancer Center | |
| Perifosine in Treating Patients With Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer | NCT00059982 | Pancreatic Canc... | perifosine | 18 Years - | National Cancer Institute (NCI) | |
| Two Chemotherapy Regimens Compared With Observation in Treating Patients With Completely Resected Pancreatic Cancer | NCT00058201 | Pancreatic Canc... | fluorouracil gemcitabine hyd... leucovorin calc... clinical observ... | 18 Years - | National Cancer Institute (NCI) | |
| Patient Derived Cancer Cell Lines in Identifying Molecular Changes in Patients With Previously Untreated Pancreatic Cancer Receiving Gemcitabine Hydrochloride-Based Chemotherapy | NCT02414100 | Pancreatic Duct... Stage IA Pancre... Stage IB Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr... Stage IV Pancre... | Laboratory Biom... Cytology Specim... | 18 Years - | Thomas Jefferson University | |
| Sorafenib With or Without Gemcitabine in Treating Patients With Metastatic Pancreatic Cancer | NCT00114244 | Stage IV Pancre... | sorafenib tosyl... gemcitabine hyd... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Pancreatic Cancer | NCT00026403 | Pancreatic Canc... | cisplatin gemcitabine hyd... radiation thera... | 18 Years - 120 Years | Alliance for Clinical Trials in Oncology | |
| Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors | NCT01233505 | Adenocarcinoma ... Adenocarcinoma ... BRCA1 Mutation ... BRCA2 Mutation ... Ovarian Mucinou... Recurrent Breas... Recurrent Colon... Recurrent Gastr... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Recta... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast... Stage IV Colon ... Stage IV Gastri... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Rectal... Unspecified Adu... | veliparib capecitabine oxaliplatin pharmacological... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Radiation Therapy in Treating Patients With Bile Duct, Gallbladder, or Pancreatic Cancer | NCT00003411 | Extrahepatic Bi... Gallbladder Can... Pancreatic Canc... | motexafin gadol... radiation thera... | 18 Years - 120 Years | University of Pittsburgh | |
| Study of Circulating Cancer Cells in Patients With Metastatic Breast, Ovarian, Colon, or Pancreatic Cancer | NCT00898781 | Breast Cancer Colorectal Canc... Ovarian Cancer Pancreatic Canc... | - | Mayo Clinic | ||
| PhII Study STA-9090 as Second or Third-Line Therapy for Metastatic Pancreas Cancer | NCT01227018 | Adenocarcinoma ... Recurrent Pancr... Stage IV Pancre... | STA-9090 Radiologic imag... blood draw | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| Gemcitabine Hydrochloride and Tanespimycin in Treating Patients With Stage IV Pancreatic Cancer | NCT00577889 | Adenocarcinoma ... Recurrent Pancr... Stage IV Pancre... | gemcitabine hyd... tanespimycin | 18 Years - | National Cancer Institute (NCI) | |
| Vismodegib and Gemcitabine Hydrochloride in Treating Patients With Advanced Pancreatic Cancer | NCT01195415 | Recurrent Pancr... Stage IV Pancre... | Gemcitabine Hyd... Laboratory Biom... Vismodegib | 18 Years - | National Cancer Institute (NCI) | |
| Gemcitabine With or Without CI-994 in Treating Patients With Advanced Pancreatic Cancer | NCT00004861 | Pancreatic Canc... | gemcitabine hyd... tacedinaline | 18 Years - | Pfizer | |
| Disease Management Program or Usual Care in Patients With Stage III or Stage IV Lung Cancer, Pancreatic Cancer, Ovarian Cancer, or Colorectal Cancer, and Their Caregivers | NCT00684801 | Colorectal Canc... Lung Cancer Ovarian Cancer Pancreatic Canc... | questionnaire a... quality-of-life... | 18 Years - | Case Comprehensive Cancer Center | |
| Combination Chemotherapy With or Without Ganitumab in Treating Patients With Previously Untreated Metastatic Pancreatic Cancer | NCT01473303 | Pancreatic Canc... | ganitumab fluorouracil irinotecan hydr... leucovorin calc... oxaliplatin placebo questionnaire a... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer | NCT00003427 | Anal Cancer Colorectal Canc... Esophageal Canc... Extrahepatic Bi... Gallbladder Can... Gastric Cancer Gastrointestina... Liver Cancer Pancreatic Canc... Small Intestine... | irinotecan hydr... oxaliplatin | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Fluorouracil With or Without Cisplatin in Treating Patients With Advanced or Metastatic Cancer of the Pancreas | NCT00003029 | Pancreatic Canc... | cisplatin fluorouracil | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Dovitinib Lactate, Gemcitabine Hydrochloride, and Capecitabine in Treating Patients With Advanced or Metastatic Solid Tumors, Pancreatic Cancer and Biliary Cancers | NCT01497392 | Adenocarcinoma ... Stage III Pancr... Stage IV Pancre... Unspecified Adu... | dovitinib lacta... gemcitabine hyd... capecitabine laboratory biom... enzyme-linked i... pharmacological... | 18 Years - | Roswell Park Cancer Institute | |
| Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery | NCT00004895 | Colorectal Canc... Constipation, I... Extrahepatic Bi... Gastric Cancer Gastrointestina... Nausea and Vomi... Ovarian Cancer Pancreatic Canc... Peritoneal Cavi... Small Intestine... | octreotide acet... | 18 Years - | Northwestern University | |
| Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Pancreatic Cancer | NCT00026403 | Pancreatic Canc... | cisplatin gemcitabine hyd... radiation thera... | 18 Years - 120 Years | Alliance for Clinical Trials in Oncology | |
| Study of Circulating Cancer Cells in Patients With Metastatic Breast, Ovarian, Colon, or Pancreatic Cancer | NCT00898781 | Breast Cancer Colorectal Canc... Ovarian Cancer Pancreatic Canc... | - | Mayo Clinic | ||
| Pembrolizumab and XL888 in Patients With Advanced Gastrointestinal Cancer | NCT03095781 | Colorectal Aden... Metastatic Panc... Recurrent Color... Recurrent Pancr... Stage III Color... Stage III Pancr... Stage IIIA Colo... Stage IIIB Colo... Stage IV Colore... Stage IV Pancre... Stage IVA Color... Stage IVA Pancr... Stage IVB Color... Stage IVB Pancr... Unresectable Pa... | XL888 Pembrolizumab | 18 Years - | Emory University | |
| Chemotherapy Compared to Biological Therapy in Treating Patients With Cancer of the Pancreas | NCT00003780 | Pancreatic Canc... | tumor infiltrat... gemcitabine hyd... | 18 Years - | National Cancer Institute (NCI) | |
| Carboplatin and Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Metastatic Pancreatic Cancer | NCT01280058 | Pancreatic Acin... Pancreatic Duct... Recurrent Pancr... Stage IV Pancre... | Carboplatin Laboratory Biom... Paclitaxel Wild-type Reovi... | 18 Years - | National Cancer Institute (NCI) | |
| Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Gastrointestinal Cancer | NCT00025532 | Colorectal Canc... Esophageal Canc... Gastric Cancer Pancreatic Canc... | iodine I 131 mo... | 19 Years - | University of California, San Francisco | |
| Gemcitabine and Erlotinib in Treating Patients With Metastatic or Recurrent Pancreatic Cancer | NCT00810719 | Pancreatic Canc... | Erlotinib gemcitabine | 18 Years - | University of California, Davis | |
| Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum | NCT00005860 | Cancer | floxuridine leucovorin calc... oxaliplatin | 18 Years - | National Cancer Institute (NCI) | |
| Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer | NCT00002475 | Breast Cancer Colorectal Canc... Kidney Cancer Lung Cancer Malignant Mesot... Pancreatic Canc... | allogeneic tumo... autologous tumo... recombinant int... recombinant int... sargramostim cyclophosphamid... | 18 Years - | National Cancer Institute (NCI) | |
| Interleukin-12 in Treating Patients With Refractory Advanced-Stage Ovarian Cancer or Abdominal Cancer | NCT00003439 | Cancer | recombinant int... | 18 Years - | National Cancer Institute (NCI) | |
| Calcitriol and Docetaxel in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer | NCT00238199 | Pancreatic Canc... | calcitriol docetaxel | 18 Years - | OHSU Knight Cancer Institute | |
| Nitrocamptothecin Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer | NCT00005869 | Pancreatic Canc... | gemcitabine hyd... rubitecan | 18 Years - | National Cancer Institute (NCI) | |
| Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity | NCT00003548 | Cancer | aminocamptothec... | 18 Years - | NYU Langone Health | |
| Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies | NCT01643499 | Acinar Cell Ade... Adenocarcinoma ... Adenocarcinoma ... Adult Primary C... Advanced Adult ... Cholangiocarcin... Cholangiocarcin... Diffuse Adenoca... Duct Cell Adeno... Intestinal Aden... Localized Unres... Metastatic Carc... Metastatic Extr... Mixed Adenocarc... Mucinous Adenoc... Mucinous Adenoc... Newly Diagnosed... Signet Ring Ade... Signet Ring Ade... Stage III Pancr... Stage IIIA Colo... Stage IIIA Gall... Stage IIIA Gast... Stage IIIA Rect... Stage IIIB Colo... Stage IIIB Gall... Stage IIIB Gast... Stage IIIB Rect... Stage IIIC Colo... Stage IIIC Gast... Stage IIIC Rect... Stage IV Gastri... Stage IV Pancre... Stage IVA Colon... Stage IVA Gallb... Stage IVA Recta... Stage IVB Colon... Stage IVB Gallb... Stage IVB Recta... Unresectable Ex... | oxaliplatin irinotecan hydr... leucovorin calc... fluorouracil laboratory biom... | 18 Years - | University of Chicago | |
| 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) | NCT00031681 | Advanced Adult ... Carcinoma of th... Estrogen Recept... Extensive Stage... Gastrointestina... HER2-negative B... Metastatic Gast... Ovarian Sarcoma Ovarian Stromal... Progesterone Re... Recurrent Adeno... Recurrent Adult... Recurrent Anal ... Recurrent Basal... Recurrent Borde... Recurrent Breas... Recurrent Cervi... Recurrent Colon... Recurrent Endom... Recurrent Esoph... Recurrent Esthe... Recurrent Extra... Recurrent Gallb... Recurrent Gastr... Recurrent Gastr... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Metas... Recurrent Midli... Recurrent Mucoe... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Prost... Recurrent Recta... Recurrent Saliv... Recurrent Small... Recurrent Small... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Small Intestine... Small Intestine... Small Intestine... Stage IV Adenoi... Stage IV Anal C... Stage IV Basal ... Stage IV Border... Stage IV Breast... Stage IV Colon ... Stage IV Endome... Stage IV Esopha... Stage IV Esthes... Stage IV Gastri... Stage IV Invert... Stage IV Lympho... Stage IV Lympho... Stage IV Midlin... Stage IV Mucoep... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Prosta... Stage IV Rectal... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc... Stage IVA Cervi... Stage IVB Cervi... Triple-negative... Unresectable Ex... Unresectable Ga... Unspecified Adu... Untreated Metas... | 7-hydroxystauro... irinotecan hydr... diagnostic labo... | 18 Years - | National Cancer Institute (NCI) | |
| Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With Chemotherapy | NCT01658943 | Pancreatic Acin... Pancreatic Duct... Recurrent Pancr... Stage IV Pancre... | Akt Inhibitor M... Fluorouracil Oxaliplatin Selumetinib | 18 Years - | National Cancer Institute (NCI) | |
| Efavirenz as Second-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer | NCT00964171 | Pancreatic Canc... | efavirenz quality-of-life... | 18 Years - | National Cancer Institute (NCI) | |
| Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract Cancer | NCT00266097 | Extrahepatic Bi... Gallbladder Can... Pancreatic Canc... | erlotinib hydro... gemcitabine hyd... oxaliplatin radiation thera... gemcitabine hyd... Oxaliplatin | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| Dovitinib Lactate, Gemcitabine Hydrochloride, and Capecitabine in Treating Patients With Advanced or Metastatic Solid Tumors, Pancreatic Cancer and Biliary Cancers | NCT01497392 | Adenocarcinoma ... Stage III Pancr... Stage IV Pancre... Unspecified Adu... | dovitinib lacta... gemcitabine hyd... capecitabine laboratory biom... enzyme-linked i... pharmacological... | 18 Years - | Roswell Park Cancer Institute | |
| Gemcitabine With or Without Tipifarnib (R115777) in Treating Patients With Advanced Pancreatic Cancer | NCT00005648 | Pancreatic Neop... | Gemcitabine wit... Gemcitabine wit... | 18 Years - | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |
| Making Decisions About Participating in a Cancer Clinical Trial for Patients With Stage II, Stage III, or Stage IV Pancreatic Cancer or Stage III or Stage IV Colon Cancer or Rectal Cancer | NCT00478010 | Colorectal Canc... Pancreatic Canc... Psychosocial Ef... | counseling inte... study of socioe... psychosocial as... quality-of-life... | 18 Years - 120 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors | NCT00003125 | Breast Cancer Esophageal Canc... Gastric Cancer Lung Cancer Pancreatic Canc... Unspecified Adu... | ALVAC-CEA vacci... aldesleukin sargramostim vaccinia-CEA va... | 18 Years - | Georgetown University | |
| Gemcitabine and Monoclonal Antibody Therapy in Treating Patients With Metastatic Cancer of the Pancreas | NCT00003797 | Pancreatic Canc... | trastuzumab gemcitabine hyd... | 18 Years - | National Cancer Institute (NCI) | |
| Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Unresectable Pancreatic Adenocarcinoma | NCT00075452 | Pancreatic Canc... | gemcitabine hyd... oxaliplatin | 18 Years - 75 Years | National Cancer Institute (NCI) | |
| Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer | NCT00544193 | Extrahepatic Bi... Gallbladder Can... Gastric Cancer Pancreatic Canc... Small Intestine... | gemcitabine hyd... polymerase chai... immunohistochem... conventional su... intraoperative ... radiation thera... | 18 Years - 70 Years | City of Hope Medical Center | |
| Carboplatin and Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Metastatic Pancreatic Cancer | NCT01280058 | Pancreatic Acin... Pancreatic Duct... Recurrent Pancr... Stage IV Pancre... | Carboplatin Laboratory Biom... Paclitaxel Wild-type Reovi... | 18 Years - | National Cancer Institute (NCI) | |
| Relationship Between Vitamin D Biomarkers and Survival in Blood Samples From Patients With Advanced Pancreatic Cancer | NCT01327794 | Pancreatic Canc... | polymorphism an... immunologic tec... laboratory biom... medical chart r... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Cisplatin, Capecitabine, Gemcitabine and Epirubicin or Docetaxel for Patients With Stage III or IV Pancreatic Cancer | NCT00966706 | Pancreatic Canc... | capecitabine cisplatin docetaxel epirubicin hydr... gemcitabine hyd... | 18 Years - 75 Years | IRCCS San Raffaele | |
| Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders | NCT00830557 | Islet Cell Tumo... Pancreatic Canc... Pancreatic Dise... | medical chart r... survey administ... biospecimen col... | 18 Years - 120 Years | Mayo Clinic | |
| Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors | NCT00004095 | Bladder Cancer Breast Cancer Colorectal Canc... Kidney Cancer Lung Cancer Pancreatic Canc... | gemcitabine hyd... irinotecan hydr... | 18 Years - 120 Years | Northwestern University | |
| Metformin Plus Modified FOLFOX 6 in Metastatic Pancreatic Cancer | NCT01666730 | Acinar Cell Ade... Duct Cell Adeno... Recurrent Pancr... Stage IV Pancre... | metformin hydro... oxaliplatin leucovorin calc... fluorouracil laboratory biom... | 18 Years - | Case Comprehensive Cancer Center | |
| Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors | NCT03682289 | Clear Cell Rena... Locally Advance... Locally Advance... Metastatic Mali... Metastatic Rena... Metastatic Urot... Metastatic Panc... Stage III Pancr... Stage III Renal... Stage IV Pancre... Stage IV Renal ... Endometrial Can... Metastatic Cast... | Ceralasertib Olaparib Durvalumab | 18 Years - | University of California, San Francisco | |
| Pioglitazone as Second-Line in Patients With Metastatic Pancreatic Cancer After Treatment With Gemcitabine | NCT00867126 | Pancreatic Canc... | pioglitazone hy... laboratory biom... questionnaire a... quality-of-life... | 18 Years - 120 Years | University of Texas Southwestern Medical Center | |
| LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal Cancer | NCT00010270 | Colorectal Canc... Esophageal Canc... Gastric Cancer Pancreatic Canc... | LMB-9 immunotox... | 18 Years - | National Cancer Institute (NCI) | |
| Prospective Cohort Study Depending on the Use of Palliative Care for Advanced Stage of Cancer Patients | NCT03222258 | Stage IV Breast... Stage IV Pancre... Stage IV Colon ... Stage IV Gastri... Stage IV Lung C... Stage IV Liver ... Malignant Hemat... Biliary Cancer ... Pediatric Leuke... Pediatric Lymph... Pediatric Brain... Pediatric Solid... | Early palliativ... Routine hospice... | - | Seoul National University Hospital | |
| Fluorouracil, External-Beam Radiation Therapy, and Gemcitabine With or Without Brachytherapy Using Phosphorus P32 in Treating Patients With Locally or Regionally Advanced Unresectable Adenocarcinoma of the Pancreas | NCT00079365 | Pancreatic Canc... | fluorouracil gemcitabine hyd... brachytherapy phosphorus P32 radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract | NCT00012246 | Colorectal Canc... Esophageal Canc... Extrahepatic Bi... Gallbladder Can... Gastric Cancer Pancreatic Canc... Small Intestine... | carcinoembryoni... incomplete Freu... sargramostim | 18 Years - | The University of Texas Medical Branch, Galveston | |
| Irinotecan and Capecitabine in Treating Patients With Solid Tumors | NCT00003867 | Cancer | capecitabine irinotecan hydr... | 18 Years - 120 Years | Montefiore Medical Center | |
| Palliative Care in Improving Quality of Life and Symptoms in Patients With Stage III-IV Pancreatic or Ovarian Cancer | NCT01927393 | Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Stage III Pancr... Stage IIIA Ovar... Stage IIIA Ovar... Stage IIIB Ovar... Stage IIIB Ovar... Stage IIIC Ovar... Stage IIIC Ovar... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... | palliative care educational int... quality-of-life... questionnaire a... telephone-based... | 21 Years - | City of Hope Medical Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
